Singulex signs agreement to co-develop the Sgx Clarity system with Tecan

Singulex, Inc., the developer and leading provider of Single Molecule Counting (SMC™) technology for clinical diagnostics and scientific discovery, today announced an agreement to co-develop the Sgx Clarity™ system with Tecan, a leading global provider of laboratory automation instruments. The partnership will incorporate Singulex's SMC technology and customized consumables onto Tecan's Freedom EVO® liquid handling platform. By integrating Singulex's proprietary ultrasensitive detection technology with Tecan's existing platform, Singulex expects to be able to commercialize the ultrasensitive immunoassay system for the in vitro diagnostics (IVD) market as early as 2016.

The Sgx Clarity System will be the most sensitive IVD immunoassay system for routine diagnostics. The fully-automated bench-top analyzer is targeted for clinical diagnostics laboratories and is being designed to be marketed by Singulex as an IVD and CE-marked device in the U.S. and global markets.

"We expect the Sgx Clarity System to be able to detect low-abundance biomarkers and pathogens with significantly greater sensitivity than any existing immunoassay IVD systems," said Guido Baechler, President and Chief Executive Officer of Singulex. "By choosing Tecan's innovative liquid handling platform, we are confident we will offer a fully-automated platform of the highest quality with a reduced time to market."

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Tecan. (2019, June 20). Singulex signs agreement to co-develop the Sgx Clarity system with Tecan. News-Medical. Retrieved on October 31, 2024 from https://www.news-medical.net/news/20140325/Singulex-signs-agreement-to-co-develop-the-Sgx-Clarity-system-with-Tecan.aspx.

  • MLA

    Tecan. "Singulex signs agreement to co-develop the Sgx Clarity system with Tecan". News-Medical. 31 October 2024. <https://www.news-medical.net/news/20140325/Singulex-signs-agreement-to-co-develop-the-Sgx-Clarity-system-with-Tecan.aspx>.

  • Chicago

    Tecan. "Singulex signs agreement to co-develop the Sgx Clarity system with Tecan". News-Medical. https://www.news-medical.net/news/20140325/Singulex-signs-agreement-to-co-develop-the-Sgx-Clarity-system-with-Tecan.aspx. (accessed October 31, 2024).

  • Harvard

    Tecan. 2019. Singulex signs agreement to co-develop the Sgx Clarity system with Tecan. News-Medical, viewed 31 October 2024, https://www.news-medical.net/news/20140325/Singulex-signs-agreement-to-co-develop-the-Sgx-Clarity-system-with-Tecan.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Boost workflow efficiency and flexibility with the next generation of Resolvex® A200 positive pressure processors